Hospital
Sutter Bay Hospitals
Sutter Bay Hospitals was paid $19.99M by Medicaid between Jan 2018 and Dec 2024, across 208 billing codes. Its largest line is 99285, emergency room visit (most serious) — 11% of everything it billed.
33Billing provider infoSUTTER BAY HOSPITALS
SAN FRANCISCO, CA 94109
SAN FRANCISCO, CA 94109
33aNPI1740348929assigned 12/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.99M
24GClaims303,701
24DCodes billed208
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#121 of 410
Median peer was paid$6.90M
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GATES, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,577 | $1.10M | |
| 2019 | 33,773 | $1.05M | |
| 2020 | 35,916 | $1.98M | |
| 2021 | 41,771 | $2.81M | |
| 2022 | 47,850 | $3.54M | |
| 2023 | 63,122 | $5.68M | |
| 2024incomplete | 46,692 | $3.83M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 1,485 | 1,377 | $2.10M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 7.8% | 18,324 | 15,524 | $1.55M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.7% | 2,641 | 2,376 | $1.33M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.2% | 5,417 | 5,060 | $833K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.9% | 1,837 | 1,793 | $786K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.5% | 2,804 | 2,676 | $701K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.4% | 3,975 | 3,424 | $675K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.1% | 2,844 | 2,100 | $620K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.1% | 5,516 | 5,092 | $611K |
| 0450 | Emergency room services | 2.8% | 7,212 | 6,333 | $570K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.3% | 4,940 | 1,800 | $465K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 2.1% | 173 | 170 | $426K |
196 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 2.1% | 4,457 | $425K |
| 99199 | Unlisted special service, procedure or report | 2.1% | 3,459 | $422K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 9,493 | $420K |
| 80053 | Comprehensive metabolic panel | 2.0% | 21,822 | $396K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.9% | 1,322 | $385K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 1.8% | 11,192 | $367K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.8% | 1,209 | $359K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 3,686 | $353K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.8% | 600 | $351K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 1,716 | $323K |
| 99201 | 1.6% | 2,375 | $311K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 24,103 | $281K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 5,633 | $255K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 3,051 | $239K |
| Q3014 | Telehealth originating site facility fee | 1.1% | 6,009 | $224K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 3,934 | $202K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,326 | $161K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,058 | $159K |
| 82077 | <1% | 2,988 | $152K | |
| J3490 | Unclassified drugs | <1% | 5,500 | $140K |
| 97039 | <1% | 3,072 | $134K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,114 | $130K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 944 | $120K |
| 84484 | <1% | 7,141 | $113K | |
| 83880 | <1% | 2,058 | $110K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,158 | $103K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,563 | $102K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 452 | $101K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 500 | $87K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 169 | $85K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,683 | $78K |
| 0510 | <1% | 1,865 | $75K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,780 | $70K |
| 92523 | <1% | 955 | $69K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 186 | $67K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,468 | $64K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 120 | $63K |
| 71250 | <1% | 112 | $58K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,081 | $56K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,075 | $56K |
| 87040 | <1% | 2,958 | $54K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 740 | $53K |
| 0270 | <1% | 1,510 | $46K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 300 | $46K |
| 83690 | <1% | 4,239 | $45K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,353 | $43K |
| 83605 | <1% | 2,380 | $39K | |
| 80061 | Lipid panel | <1% | 2,126 | $39K |
| 92134 | <1% | 411 | $37K | |
| 92526 | <1% | 393 | $36K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,859 | $35K |
| 83735 | <1% | 3,791 | $35K | |
| 85610 | <1% | 5,039 | $33K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 38 | $33K |
| 80143 | <1% | 467 | $32K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 536 | $32K |
| 81001 | <1% | 6,196 | $31K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,023 | $31K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,109 | $30K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,663 | $29K |
| 0250 | <1% | 942 | $29K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,341 | $27K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,023 | $25K |
| 86481 | <1% | 256 | $23K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 108 | $23K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $22K |
| 85730 | <1% | 2,472 | $22K | |
| 80197 | <1% | 1,348 | $22K | |
| 99070 | <1% | 1,317 | $20K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 528 | $20K |
| 93971 | <1% | 67 | $18K | |
| 80179 | <1% | 381 | $18K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,731 | $18K |
| 81003 | <1% | 3,377 | $18K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,024 | $17K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 124 | $16K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 30 | $16K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 106 | $16K |
| 70496 | <1% | 32 | $15K | |
| 0760 | <1% | 290 | $15K | |
| 82947 | <1% | 1,274 | $15K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 886 | $14K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,060 | $13K |
| 87186 | <1% | 840 | $13K | |
| 84702 | <1% | 1,446 | $13K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 466 | $12K |
| 86803 | <1% | 671 | $12K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 40 | $12K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 188 | $12K |
| 81025 | <1% | 1,817 | $12K | |
| 86900 | <1% | 1,993 | $12K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 375 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 195 | $11K |
| 76830 | Ultrasound, transvaginal | <1% | 80 | $11K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 663 | $11K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 76 | $10K |
| 86850 | <1% | 1,175 | $10K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 782 | $10K |
| 96367 | <1% | 78 | $9K | |
| 86901 | <1% | 1,891 | $9K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 144 | $9K |
| 76770 | <1% | 100 | $8K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 559 | $8K |
| 85379 | <1% | 397 | $8K | |
| 0750 | <1% | 40 | $7K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 368 | $7K |
| 88342 | <1% | 235 | $7K | |
| 86140 | <1% | 788 | $7K | |
| 74183 | <1% | 12 | $7K | |
| 74174 | <1% | 12 | $7K | |
| 77066 | Tomosynthesis, mammo | <1% | 26 | $6K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 119 | $6K |
| 82728 | <1% | 295 | $6K | |
| 87340 | <1% | 395 | $6K | |
| 70498 | <1% | 16 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 988 | $6K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 91 | $6K |
| 86480 | <1% | 69 | $5K | |
| 87077 | <1% | 261 | $5K | |
| 97139 | <1% | 144 | $5K | |
| 77080 | <1% | 15 | $5K | |
| 82805 | <1% | 85 | $5K | |
| 87400 | <1% | 779 | $5K | |
| 84439 | <1% | 294 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 632 | $4K |
| 83789 | <1% | 161 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 194 | $4K |
| 86592 | <1% | 659 | $4K | |
| 82607 | <1% | 133 | $4K | |
| 73630 | <1% | 70 | $4K | |
| 84145 | <1% | 118 | $4K | |
| 87581 | <1% | 71 | $4K | |
| 92133 | <1% | 44 | $3K | |
| 87486 | <1% | 71 | $3K | |
| 82570 | <1% | 335 | $3K | |
| 88142 | <1% | 497 | $3K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12 | $3K |
| 85652 | <1% | 713 | $3K | |
| 83540 | <1% | 251 | $3K | |
| 83550 | <1% | 196 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 219 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 278 | $3K |
| 0160 | <1% | 21 | $3K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 285 | $3K |
| 82043 | <1% | 209 | $2K | |
| 76642 | <1% | 15 | $2K | |
| 88341 | <1% | 16 | $2K | |
| 87081 | <1% | 380 | $2K | |
| 97750 | <1% | 28 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 31 | $2K |
| 82550 | <1% | 212 | $2K | |
| 87420 | <1% | 235 | $2K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 398 | $2K |
| 0762 | <1% | 20 | $2K | |
| 93017 | <1% | 29 | $2K | |
| 84100 | <1% | 288 | $2K | |
| 86644 | <1% | 110 | $2K | |
| 82105 | <1% | 59 | $2K | |
| 82977 | <1% | 145 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 904 | $1K |
| 86704 | <1% | 88 | $1K | |
| 84153 | <1% | 55 | $1K | |
| 87070 | <1% | 94 | $1K | |
| 87430 | <1% | 106 | $1K | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 34 | $1K |
| 86706 | <1% | 64 | $1K | |
| 88313 | <1% | 54 | $1K | |
| 92083 | <1% | 18 | $807.64 | |
| 86665 | <1% | 40 | $774.71 | |
| 83615 | <1% | 52 | $613.14 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 15 | $601.97 |
| 92250 | <1% | 13 | $523.21 | |
| 73562 | <1% | 12 | $519.98 | |
| 88312 | <1% | 37 | $504.10 | |
| 84550 | <1% | 28 | $499.19 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 53 | $493.84 |
| 71020 | <1% | 26 | $474.97 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 12 | $371.05 |
| 84132 | <1% | 43 | $354.26 | |
| 86664 | <1% | 27 | $340.17 | |
| 85027 | <1% | 52 | $308.48 | |
| 71010 | <1% | 20 | $290.60 | |
| 73610 | <1% | 13 | $252.56 | |
| 88307 | <1% | 13 | $252.16 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 16 | $247.43 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 44 | $215.14 |
| 88363 | <1% | 14 | $205.11 | |
| 86663 | <1% | 13 | $191.89 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 14 | $185.26 |
| 84156 | <1% | 38 | $160.01 | |
| 87088 | <1% | 12 | $91.46 | |
| 87205 | <1% | 14 | $72.70 | |
| 0272R | 0% | 16 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 15 | $0.00 |
| 0370R | 0% | 16 | $0.00 | |
| 0250R | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGATES, JOHN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Sutter Bay Hospitals | Castro Valley, CA | $52.65M |
| Sutter Bay Hospitals | Oakland, CA | $46.80M |
| Sutter Bay Hospitals | Berkeley, CA | $43.78M |
| Sutter Bay Hospitals | Lakeport, CA | $39.50M |
| Sutter Bay Hospitals | Santa Rosa, CA | $35.23M |
| Sutter Bay Hospitals | Antioch, CA | $29.48M |
| Sutter Bay Hospitals | Burlingame, CA | $17.15M |
| Sutter Bay Hospitals | San Francisco, CA | $14.94M |
| Sutter Bay Hospitals | Novato, CA | $11.12M |
| Sutter Bay Hospitals | San Francisco, CA | $6.79M |
| Sutter Bay Hospitals | Lakeport, CA | $3.99M |
| Sutter East Bay Hospitals | Antioch, CA | $3.45M |
| Sutter Bay Hospitals | Burlingame, CA | $1.98M |
| Sutter Bay Hospitals | Lakeport, CA | $1.72M |
| Sutter East Bay Hospitals | Oakland, CA | $1.10M |
| Sutter Bay Hospitals | San Francisco, CA | $1.08M |
| Sutter East Bay Hospitals | Berkeley, CA | $946K |
| Sutter West Bay Hospitals | San Francisco, CA | $186K |
| Magnetic Imaging Affiliates, LLC | Oakland, CA | $112K |
| Sutter Bay Hospitals | Berkeley, CA | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.